The Cogstate Blog

Expert perspectives on improving cognitive measures from clinical trials to clinical practice.

The International Shopping List Test in Alzheimer’s Disease Clinical Trials

October 19, 2017

The Cogstate International Shopping List Test (ISLT) is a word list learning test that has several advantages for sensitively measuring episodic memory in global clinical trials, including standardization of administration, cultural appropriateness, ease of translation and ecological validity.

Key Takeaways from the 2017 National Alzheimer’s Summit

October 12, 2017

By 2050, more than 13 million Americans are estimated to be living with Alzheimer’s disease, and the costs of care is expected to mount to over a trillion dollars. In this video, Cogstate CEO, Brad O’Connor, discusses key takeaways from his experience presenting at the National Alzheimer’s Summit hosted by UsAgainstAlzheimer’s.

Subject Eligibility Review and Diagnostic Adjudication

September 22, 2017

Dr. Edward Bartolic, Senior Scientific Director at Cogstate, gives an overview and case example of Subject Eligibility Review and Diagnostic Adjudication solution, an independent check of key screening data by expert clinicians to ensure that a subject fits with the key clinical eligibility criteria of a protocol.

1 2 3

How can we help you optimize the measurement of brain health?

Please fill out the form to get in touch